Anavex Life Sciences Corp. (AVXL)
4.35
+0.25
(+6.10%)
USD |
NASDAQ |
Feb 09, 16:00
4.36
+0.01
(+0.23%)
After-Hours: 20:00
Anavex Life Sciences Total Liabilities (Quarterly) : 6.371M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CorMedix, Inc. | 376.73M |
| Verastem, Inc. | 192.38M |
| Ocugen, Inc. | 54.06M |
| AnaptysBio, Inc. | 382.51M |
| Replimune Group, Inc. | 123.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.99M |
| Shareholders Equity (Quarterly) | 126.62M |
| Current Ratio | 20.87 |